Worldwide Distribution-USA (nationwide) including DC and the states of AK, AL, AR, AZ, CA, CO, CT, FL, IL, IN, KS, LA, ME, MI, MO, MS, NC, ND, NE, NJ, NY, OH, OK, OR, PA, TN, TX, UT, VA, WA, and WI, and the countries of Canada, Australia, India, Austria, Japan, Czech Republic, Seoul Korea, France, Venezuela, Germany, Luxembourg, Spain, and Switzerland.
Description du dispositif
Apollo" Revision/Constrained Knee System: || SZ0-16MM AK CCK TIB INSER || SZ1-11MM AK CCK TIB INSER || SZ1-16MM AK CCK TIB INSER || SZ1-22MM AK CCK TIB INSER || SZ1-30MM AK CCK TIB INSER || SZ2-11MM AK CCK TIB INSER || SZ2-13MM AK CCK TIB INSER || SZ2-16MM AK CCK TIB INSER || SZ2-22MM AK CCK TIB INSER || SZ2-30MM AK CCK TIB INSER || SZ3-16MM AK CCK TIB INSER || SZ3-22MM AK CCK TIB INSER || SZ3-25MM AK CCK TIB INSER || SZ4-13MM AK CCK TIB INSER || SZ4-16MM AK CCK TIB INSER || SZ5-11MM AK CCK TIB INSER
“The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.